Directori de persones
Milica Bozic

Milica Bozic

Grau: Doctor/a

973 70 29 52 / 2212
mbozic(ELIMINAR)@irblleida.cat

ResearcherID: http://www.researcherid.com/rid/B-7425-2009

Publicacions

  • Borràs, Mercè; Cambray, Serafí; Crespo-Masip, Maria; Pérez-Fontán, Miguel; Bozic, Milica; Bermudez-López, Marcelino; Fernández, Elvira; Betriu, Àngels; Valdivielso, José M.

    Peritoneal Dialysis Is an Independent Factor Associated to Lower lntima Media Thickness in Dialysis Patients Free From Previous Cardiovascular Disease

    Frontiers in physiology 9 1743-1743. .

    [doi:10.3389/fphys.2018.01743]

  • Caus, Maite; Bozic, Milica; Fernandez, Elvira; Valdivielso, Jose M.

    DELETION OF VITAMIN D RECEPTOR EXCLUSIVELY IN VASCULAR SMOOTH MUSCLE CELLS PREVENTS VASCULAR CALCIFICATION

    NEPHROLOGY DIALYSIS TRANSPLANTATION 33 159-159. .

  • Bozic M; Betriu A; Bermudez-Lopez M; Ortiz A; Fernandez E; Valdivielso JM

    Association of FGF-2 Concentrations with Atheroma Progression in Chronic Kidney Disease Patients

    Clinical Journal Of The American Society Of Nephrology 13 577-584. .

    [doi:10.2215/CJN.07980717]

  • Bozic M; Méndez-Barbero N; Gutiérrez-Muñoz C; Betriu A; Egido J; Fernández E; Martín-Ventura JL; Valdivielso JM; Blanco-Colio LM

    Combination of biomarkers of vascular calcification and sTWEAK to predict cardiovascular events in chronic kidney disease

    Atherosclerosis 270 13-20. .

    [doi:10.1016/j.atherosclerosis.2018.01.011]

  • Khan AUH; Allende-Vega, N; Gitenay, D; Gerbal-Chaloin, S; Gondeau, C; Vo, DN; Belkahla, S; Orecchioni, S; Talarico, G; Bertolini, F; Bozic, M; Valdivielso, JM; Bejjani, F; Jariel, I; Lopez-Mejia, IC; Fajas, L; Lecellier, CH; Hernandez, J; Daujat, M; Villalba, M

    The PDK1 Inhibitor Dichloroacetate Controls Cholesterol Homeostasis Through the ERK5/MEF2 Pathway

    SCIENTIFIC REPORTS 7 10654-10654. .

    [doi:10.1038/s41598-017-10339-5]

  • Torremade, N; Bozic, M; Goltzman, D; Fernandez, E; Valdivielso, JM

    Effects of the Administration of 25(OH) Vitamin D3 in an Experimental Model of Chronic Kidney Disease in Animals Null for 1-Alpha-Hydroxylase

    PLOS ONE 12 -. .

    [doi:10.1371/journal.pone.0170654]

  • Bozic, M; Valdivielso, JM

    Functional Distribution and Regulation of the NMDAR in the Kidney, Heart and Parathyroid Gland

    Receptors Series 30 51-68. .

    [doi:10.1007/978-3-319-49795-2_3]

  • Torremade, N; Bozic, M; Panizo, S; Barrio-Vazquez, S; Fernandez-Martin, JL; Encinas, M; Goltzman, D; Arcidiacono, MV; Fernandez, E; Valdivielso, JM

    Vascular Calcification Induced by Chronic Kidney Disease Is Mediated by an Increase of 1 alpha-Hydroxylase Expression in Vascular Smooth Muscle Cells

    JOURNAL OF BONE AND MINERAL RESEARCH 31 1865-1876. .

    [doi:10.1002/jbmr.2852]

  • Bozic, M; Guzman, C; Benet, M; Sanchez-Campos, S; Garcia-Monzon, C; Gari, E; Gatius, S; Valdivielso, JM; Jover, R

    Hepatocyte vitamin D receptor regulates lipid metabolism and mediates experimental diet-induced steatosis

    JOURNAL OF HEPATOLOGY 65 748-757. .

    [doi:10.1016/j.jhep.2016.05.031]

  • Jover, R; Bozic, M; Guzman, C; Sanchez-Campos, S; Garcia-Monzon, C; Valdivielso, JM

    VITAMIN D RECEPTOR IS UP-REGULATED IN NAFLD HEPATOCYTES AND IS REQUIRED FOR HIGH FAT DIET-INDUCED STEATOSIS IN APOE(-/-) MICE LIVER

    JOURNAL OF HEPATOLOGY 64 682-682. .

    [doi:10.1016/S0168-8278(16)01294-0]

  • Bozic M; Álvarez Á; de Pablo C; Sanchez-Niño MD; Ortiz A; Dolcet X; Encinas M; Fernandez E; Valdivielso JM

    Impaired Vitamin D Signaling in Endothelial Cell Leads to an Enhanced Leukocyte-Endothelium Interplay: Implications for Atherosclerosis Development

    PLOS ONE 10 -. .

    [doi:10.1371/journal.pone.0136863]

  • Bozic M; Valdivielso JM

    The potential of targeting NMDA receptors outside the CNS

    Expert Opinion On Therapeutic Targets 19 399-413. .

    [doi:10.1517/14728222.2014.983900]

Projectes

  • Unraveling the role of piwi-interacting RNAs in the pathogenesis of obesity-induced kidney disease. Identification of potential biomarkers and therapeutic targets (RENOPIWI)
  • Descifrando el papel de SNCA en la regulación de la autofagia y el daño renal: implicaciones mecanísticas, terapéuticas y pronósticas.
  • Contrato Miguel Servet - RRHH
  • Contrato Miguel Servet - Proyecto
  • Papel del receptor NMDA en el daño renal inducido por hiperlipidemia. Estudio de los mecanismos moleculares y posibles implicaciones terapéuticas
  • CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA CIENTIFICA BASICA PER A LA CARACTERITZACIO D'UN PERFIL LIPIDOMICO Y LIPIDICO DE RIESGO ATEROGENERICO Y DE MORBIMORTALIDAD CARDIOVASCUAL EN LA ENFERMEDAD RENAL CRONICA (ESTADIOS 3 A 5), ESTUDIO PROSPECTIVO NEFRONA.
  • Papel de la expresión renal de alfa sinucleina en la enfermedad renal crónica. Implicaciones en la patogénesis de la fibrosis renal
  • IDENTIFYING PREDICTORS OF CARDIOVASCULAR EVENTS IN CHRONIC KIDNEY DISEASE. A COHORTS SUBSTUDY WITHIN THE NEFRONA STUDY
  • PAPEL DE LA FALTA DE VITAMINA D EN LA PROGRESION DE LA PLACA ATEROSCLEROTICA. IMPLICACIONES ENF LA ARTERIOPATIA UREMICA
  • PROGRAMA DE BEQUES PER A PERSONAL INVESTIGADOR NOVELL (FI)